Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Nobuhiko Mizuno"'
Autor:
Takayuki Hirano, Kousuke Yonezawa, Takashi Kawahara, Nobuhiko Mizuno, Hiroyuki Hayashi, Yuta Karibe, Jun Asano, Shusei Fusayasu, Kazuhide Makiyama, Hiroji Uemura, Junichi Ohta, Masatoshi Moriyama
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 852-858 (2024)
Introduction: There have been few reports of patients for whom a cancer gene panel test for solid tumors revealed the simultaneous presence of BRCA mutation and microsatellite instability (MSI)-high status. BRCA mutations have been reported in 13% of
Externí odkaz:
https://doaj.org/article/59e2041e93ca45caab52e298803df5f2
Autor:
Seijiro Koshimune, Mitsuko Kosaka, Nobuhiko Mizuno, Hiromasa Yamamoto, Tomoyuki Miyamoto, Kohta Ebisui, Shinichi Toyooka, Aiji Ohtsuka
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Octamer-binding transcription factor 4A (OCT4A) is essential for cell pluripotency and reprogramming both in humans and mice. To date, however, the function of human OCT4 in somatic and/or tumour tissues is largely unknown. Method
Externí odkaz:
https://doaj.org/article/c49046ca89614d1e9b8906dc6f82f864
Autor:
Koichi Uemura, Kenta Yoshida, Masahiro Inoue, Nobuhiko Mizuno, Takayuki Murakami, Takashi Kawahara, Hiroji Uemura, Jiro Kumagai, Futoshi Tsuchiya
Publikováno v:
Urology Case Reports, Vol 17, Iss C, Pp 131-133 (2018)
Externí odkaz:
https://doaj.org/article/5a96a4bfff884d50bf4b3b20fa23fd65
Publikováno v:
Ichthyological Research. 70:82-90
Autor:
Takashi Kawahara, Masahiro Yao, Yushi Araki, Nobuhiko Mizuno, Reona Nishimura, Kazuhiro Namura, Ichiro Ikeda, Hiroji Uemura, Sachi Fukui-Kawaura, Koichi Uemura
Publikováno v:
Oncotarget
Background: High-risk non-muscle invasive bladder cancer (NMIBC) is thought to be associated with a higher risk of recurrence and progression. A recent study revealed that a high De Ritis ratio was a risk factor in some solid malignancies. This study
Autor:
Mitsuko Kosaka, Shinichi Toyooka, Nobuhiko Mizuno, Aiji Ohtsuka, Seijiro Koshimune, Kohta Ebisui, Tomoyuki Miyamoto, Hiromasa Yamamoto
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer
BMC Cancer
Background Octamer-binding transcription factor 4A (OCT4A) is essential for cell pluripotency and reprogramming both in humans and mice. To date, however, the function of human OCT4 in somatic and/or tumour tissues is largely unknown. Methods RT-PCR
Autor:
Tetsuro Sasada, Akihito Hashizume, Ryosuke Jikuya, Kentaro Muraoka, Takeshi Kishida, Tomoyuki Yokose, Masato Yasui, Masahiko Sakaguchi, Yohei Miyagi, Yoshiyasu Nakamura, Susumu Umemoto, Masaki Kawai, Tomoyuki Tatenuma, Nobuhiko Mizuno, Mitsuyo Yoshihara
Publikováno v:
Cancer Immunology, Immunotherapy. 69:2041-2051
Recently, the effectiveness of anti-programmed death 1 (PD-1) antibody therapy in the treatment of renal cell carcinoma (RCC) has been established. Nevertheless, efficacy has been reported to be limited to only 10–30% of patients. To develop more e
Autor:
Kyohei Irie, Nobuhiko Mizuno, Tomoyuki Miyamoto, Aiji Ohtsuka, Hiromasa Yamamoto, Shinichi Toyooka, Hisashi Masuyama, Mitsuko Kosaka
Publikováno v:
Cancer Research. 82:5125-5125
Background: It is largely unclear whether octamer-binding transcription factor 4A (OCT4A, OCT3/4A) functions physiologically or pathologically in adult somatic tissues and related cancers. We have recently identified OCT4A translation in a human canc
Publikováno v:
Stem Cells. 36:1341-1354
The role of octamer-binding transcription factor 4 (OCT4) in human cancer is still debated. Although many studies have been published on human OCT4, determining which of the findings are accurate or which are false-positives is currently challenging.
Autor:
Kunio Yanagimoto, Sayuki Kawabata, Motoki Sato, Nobuhiko Mizuno, Naoki Ezawa, Yoshiharu Ogo, Tsuneaki Yoshinaga, Masahide Yazaki
Publikováno v:
The Japanese Journal of Urology. 109:140-143
Primary bladder amyloidosis is a rare disease, with approximately 200 cases documented in the literature. We herein present a 85-year-old Japanese man who has undergone a transurethral resection of a bladder tumor (TURBT) and has regularly been follo